Chlocibutamine

氯桂丁胺

Report date: 2025/02/21 14:21:38
NME

Base Information

Drug NameChlocibutamine
Drug Alias NameLvguidinganGui butylamine chlorineGui chlorine butylamine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type II alpha subunit inhibitors
TargetsSodium channel protein type II alpha subunit
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Boliweikang Medical Research InstitutePeking University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Boliweikang Medical Research Institute
Active IndicationsN/A
Inactive IndicationsEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A